Advance Pharmalab Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -17.68%
- Profit Growth 21.97%
- Ebitda 112.55%
- Net Worth 3.35%
- Total Assets -0.72%
About Advance Pharmalab
Advance Pharmalab Limited (APL) is a Public Limited Indian Non-Government Company incorporated in India on 25 November 1994 and has a history of 30 years and three months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kalpana Gandhi, Raj Gandhi, Prabhat Thakor, and Two other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1994PLC023682
- Company No.
023682
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Nov 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Advance Pharmalab Limited offer?
Advance Pharmalab Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Advance Pharmalab?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpana Gandhi  | Whole-Time Director | 01-Oct-2005 | Current |
| Raj Gandhi | Whole-Time Director | 01-Oct-2005 | Current |
| Prabhat Thakor | Director | 01-Nov-2022 | Current |
| Nitinkumar Thakor | Director | 01-Nov-2022 | Current |
| Vikas Gandhi | Director | 01-Nov-2022 | Current |
Financial Performance of Advance Pharmalab.
Advance Pharmalab Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.68% decrease. The company also saw a substantial improvement in profitability, with a 21.97% increase in profit. The company's net worth moved up by a moderate rise of 3.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advance Pharmalab?
In 2019, Advance Pharmalab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advance Pharmalab?
Unlock and access historical data on people associated with Advance Pharmalab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advance Pharmalab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advance Pharmalab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
